✦ LIBER ✦

Sequence and chemistry requirements for a novel aptameric oligonucleotide inhibitor of EGF receptor tyrosine kinase activity

✍ Scribed by Saghir Akhtar; Debbie Dunnion; David Poyner; John Ackroyd; Mike Bibby; John Double

Book ID: 113993061
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 724 KB
Volume: 63
Category: Article
ISSN: 0006-2952
DOI: 10.1016/s0006-2952(02)00985-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and structure-activity studies

Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor-associated tyrosine kinase activity

✍ Chen, Huixiong; Boiziau, Janine; Parker, Fabienne; Maroun, Rachid; Tocque, Bruno 📂 Article 📅 1993 🏛 American Chemical Society 🌐 English ⚖ 660 KB

Novel 4-Anilinoquinazolines with C-6 Car

Novel 4-Anilinoquinazolines with C-6 Carbon-Linked Side Chains: Synthesis and Structure—Activity Relationship of a Series of Potent, Orally Active, EGF Receptor Tyrosine Kinase Inhibitors.

✍ Laurent F. A. Hennequin; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 13 KB 👁 2 views

Tyrosine kinase activity of purified rec

Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor β-receptor (β-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases

✍ Guido J.R. Zaman; Paul M.F. Vink; Antoon A. van den Doelen; Gerrit H. Veeneman; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Tyrosine Kinase Inhibitors. 14. Structur

Tyrosine Kinase Inhibitors. 14. Structure−Activity Relationships for Methyl- amino-Substituted Derivatives of 4-[(3-Bromophenyl)amino]-6-(methylamino)- pyrido[3,4- d ]pyrimidine (PD 158780), a Potent and Specific Inhibitor of the Tyrosine Kinase Activity of Receptors for the EGF Family of Growth Factors

✍ Rewcastle, Gordon W.; Murray, Donna K.; Elliott, William L.; Fry, David W.; Howa 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 135 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Angiogenesis is an important process in cell development, especially in cancer. Vascular endothelial growth factor (VEGF) signaling is an important regulator of angiogenesis. Several therapies that act against VEGF signal transduction have been developed, including YN968D1, which is a potent inhibit